| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.1M | — | +1982.8% |
| R&D Expense | $1K | — | -94.4% |
| SG&A Expense | $567K | — | -85.6% |
| Operating Income | -$1.2M | — | +74.4% |
| Pre-tax Income | $537K | — | +111.8% |
| Income Tax | $0 | — | — |
| Net Income | $537K | — | +111.8% |
| EPS (Basic) | $0.02 | — | +106.7% |
| EPS (Diluted) | $0.02 | — | +106.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $2.1M | +515.2% | +1364.4% |
| Accounts Receivable | $1.7M | +28.6% | +30.6% |
| Current Assets | $5.1M | +158.8% | +177.7% |
| Total Assets | $15.6M | +18.3% | +32.4% |
| Current Liabilities | $5.5M | +5.5% | -11.5% |
| Total Liabilities | $5.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$385K | — | +79.1% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $1.2M | — | — |
| -11.5% |
| Stockholders' Equity | $10.1M | +26.6% | +88.5% |